US Patent 10280228 Treatment with anti-ErbB2 antibodies
Patent 10280228 was granted and assigned to Genentech on May, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 12, 2018
Date of Patent
May 7, 2019
Patent Applicant
Patent Application Number
16186756
Patent Citations
Patent Citations Received
•••
Patent Inventor Names
Sharon A. Baughman
0
Steven Shak
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10280228 Treatment with anti-ErbB2 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
